...
首页> 外文期刊>Cellular and Molecular Neurobiology >Kratom Alkaloids, Natural and Semi-Synthetic, Show Less Physical Dependence and Ameliorate Opioid Withdrawal
【24h】

Kratom Alkaloids, Natural and Semi-Synthetic, Show Less Physical Dependence and Ameliorate Opioid Withdrawal

机译:Kratom生物碱,天然和半合成,表现出较少的物理依赖性和改良阿片类药物

获取原文
获取原文并翻译 | 示例
           

摘要

Chronic administration of opioids produces physical dependence and opioid-induced hyperalgesia. Users claim the Thai traditional tea "kratom" and component alkaloid mitragynine ameliorate opioid withdrawal without increased sensitivity to pain. Testing these claims, we assessed the combined kratom alkaloid extract (KAE) and two individual alkaloids, mitragynine (MG) and the analog mitragynine pseudoindoxyl (MP), evaluating their ability to produce physical dependence and induce hyperalgesia after chronic administration, and as treatments for withdrawal in morphine-dependent subjects. C57BL/6J mice (n = 10/drug) were administered repeated saline, or graded, escalating doses of morphine (intraperitoneal; i.p.), kratom alkaloid extract (orally, p.o.), mitragynine (p.o.), or MP (subcutaneously, s.c.) for 5 days. Mice treated chronically with morphine, KAE, or mitragynine demonstrated significant drug-induced hyperalgesia by day 5 in a 48 degrees C warm-water tail-withdrawal test. Mice were then administered naloxone (10 mg/kg, s.c.) and tested for opioid withdrawal signs. Kratom alkaloid extract and the two individual alkaloids demonstrated significantly fewer naloxone-precipitated withdrawal signs than morphine-treated mice. Additional C57BL/6J mice made physically dependent on morphine were then used to test the therapeutic potential of combined KAE, mitragynine, or MP given twice daily over the next 3 days at either a fixed dose or in graded, tapering descending doses. When administered naloxone, mice treated with KAE, mitragynine, or MP under either regimen demonstrated significantly fewer signs of precipitated withdrawal than control mice that continued to receive morphine. In conclusion, while retaining some liabilities, kratom, mitragynine, and mitragynine pseudoindoxyl produced significantly less physical dependence and ameliorated precipitated withdrawal in morphine-dependent animals, suggesting some clinical value.
机译:长期服用阿片类药物会产生身体依赖和阿片类药物诱导的痛觉过敏。用户声称泰国传统茶“kratom”和成分生物碱mitragynine可以改善阿片类药物的戒断,而不会增加对疼痛的敏感性。为了验证这些说法,我们评估了联合克拉通生物碱提取物(KAE)和两种单独的生物碱,即米特拉吉宁(MG)和模拟米特拉吉宁假吲哚氧基(MP),评估了它们在慢性给药后产生身体依赖性和诱发痛觉过敏的能力,以及作为吗啡依赖受试者戒断的治疗。C57BL/6J小鼠(n=10/种药物)重复给予生理盐水,或分级、递增剂量的吗啡(腹腔注射;i.p.)、克拉通生物碱提取物(口服,p.o.)、米特拉吉宁(p.o.)或MP(皮下注射,s.c.)5天。在48摄氏度温水停尾试验中,长期服用吗啡、KAE或米特拉格宁的小鼠在第5天表现出明显的药物诱导的痛觉过敏。然后给小鼠服用纳洛酮(10mg/kg,s.c.),并测试阿片类戒断症状。Kratom生物碱提取物和两种单独的生物碱显示,纳洛酮诱发的戒断症状明显少于吗啡治疗的小鼠。然后,使用身体依赖吗啡的C57BL/6J小鼠,在接下来的3天内,以固定剂量或逐渐递减的分级剂量,每天两次联合给予KAE、米特拉吉宁或MP,以测试其治疗潜力。服用纳洛酮后,在这两种方案下使用KAE、米特拉吉宁或MP的小鼠与继续服用吗啡的对照小鼠相比,表现出明显较少的突然戒断症状。总之,虽然保留了一些责任,但kratom、mitragynine和mitragynine pseudoindoxy在吗啡依赖动物中产生的身体依赖性显著降低,并改善了催促戒断,表明了一些临床价值。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号